Analysis
new
Racine
Analysis
new
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster protein - spike

Terms

14protein
8spike
8angiotensin
10receptor
4converting
4enzyme
4binding
8inhibitors

Associations

Freq.WeightAssociation
55protein - spike
33protein - receptor
44angiotensin - receptor
44angiotensin - enzyme
44converting - enzyme
44angiotensin - converting
33enzyme - receptor
33converting - receptor
33binding - protein
33angiotensin - inhibitors
Documents par ordre de pertinence
000352 (2020) James H. Diaz [États-Unis]Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
000615 (2020) Ankit B. Patel [États-Unis] ; Ashish Verma [États-Unis]COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
000643 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000154 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000182 (2020) Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000244 (2020) Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000540 (2020) Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis]Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
000151 (2020) Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine]Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
000173 (2020) Gabriela M. Kuster [Suisse] ; Otmar Pfister [Suisse] ; Thilo Burkard [Suisse] ; Qian Zhou [Suisse] ; Raphael Twerenbold [Suisse] ; Philip Haaf [Suisse] ; Andreas F. Widmer [Suisse] ; Stefan Osswald [Suisse]SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
000379 (2020) Roujian Lu [République populaire de Chine] ; Xiang Zhao [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Bo Yang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Wenling Wang [République populaire de Chine] ; Hao Song [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Na Zhu [République populaire de Chine] ; Yuhai Bi [République populaire de Chine] ; Xuejun Ma [République populaire de Chine] ; Faxian Zhan [République populaire de Chine] ; Liang Wang [République populaire de Chine] ; Tao Hu [République populaire de Chine] ; Hong Zhou [République populaire de Chine] ; Zhenhong Hu [République populaire de Chine] ; Weimin Zhou [République populaire de Chine] ; Li Zhao [République populaire de Chine] ; Jing Chen [République populaire de Chine] ; Yao Meng [République populaire de Chine] ; Ji Wang [République populaire de Chine] ; Yang Lin [République populaire de Chine] ; Jianying Yuan [République populaire de Chine] ; Zhihao Xie [République populaire de Chine] ; Jinmin Ma [République populaire de Chine] ; William J. Liu [République populaire de Chine] ; Dayan Wang [République populaire de Chine] ; Wenbo Xu [République populaire de Chine] ; Edward C. Holmes [Australie] ; George F. Gao [République populaire de Chine] ; Guizhen Wu [République populaire de Chine] ; Weijun Chen [République populaire de Chine] ; Weifeng Shi [République populaire de Chine] ; Wenjie Tan [République populaire de Chine]Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
000395 (2020) Xintian Xu [République populaire de Chine] ; Ping Chen [République populaire de Chine] ; Jingfang Wang [République populaire de Chine] ; Jiannan Feng [République populaire de Chine] ; Hui Zhou [République populaire de Chine] ; Xuan Li [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Pei Hao [République populaire de Chine]Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
000553 (2020) Murray Esler ; Danielle Esler [Australie]Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
000669 (2020) Qiong Wang ; Ye Qiu ; Jin-Yan Li ; Zhi-Jian Zhou ; Ce-Heng Liao ; Xing-Yi GeA Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility
000723 (2016) Yining He ; Zhiwen Xie ; Jinglong Dai ; Yanjie Cao ; Jinlian Hou ; Yansheng Zheng ; Tianchao Wei ; Meilan Mo ; Ping WeiResponses of the Toll-like receptor and melanoma differentiation-associated protein 5 signaling pathways to avian infectious bronchitis virus infection in chicks
000757 (2011) Amruta S. Bhat [Inde] ; H. S. Savithri [Inde]Investigations on the RNA binding and phosphorylation of groundnut bud necrosis virus nucleocapsid protein
000162 (2020) Luca Perico [Italie] ; Ariela Benigni [Italie] ; Giuseppe Remuzzi [Italie]Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
000199 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis]Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
000280 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000414 (2020) Naveen Vankadari [Australie] ; Jacqueline A. Wilce [Australie]Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.
000442 (2020) Linlin Zhang [Allemagne] ; Daizong Lin [Allemagne] ; Xinyuanyuan Sun [Allemagne] ; Ute Curth [Allemagne] ; Christian Drosten [Allemagne] ; Lucie Sauerhering [Allemagne] ; Stephan Becker [Allemagne] ; Katharina Rox [Allemagne] ; Rolf Hilgenfeld [Allemagne]Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
000566 (2020) George ThomsonCOVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond?
000729 (2015) Tsuneyuki Masuda ; Satoshi Murakami [Japon] ; Osamu Takahashi [Japon] ; Ayako Miyazaki ; Seiichi Ohashi ; Hiroshi Yamasato ; Tohru SuzukiNew porcine epidemic diarrhoea virus variant with a large deletion in the spike gene identified in domestic pigs
000731 (2015) Xiaobo Wang [République populaire de Chine] ; Jianfei Chen [République populaire de Chine] ; Da Shi [République populaire de Chine] ; Hongyan Shi [République populaire de Chine] ; Xin Zhang [République populaire de Chine] ; Jing Yuan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Li Feng [République populaire de Chine]Immunogenicity and antigenic relationships among spike proteins of porcine epidemic diarrhea virus subtypes G1 and G2
000739 (2014) Hussain Badani [États-Unis] ; Robert F. Garry [États-Unis] ; William C. Wimley [États-Unis]Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity☆
000747 (2013) Amit K. Halder [Inde] ; Achintya Saha [Inde] ; Tarun Jha [Inde]Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors
000771 (2009) Masaru Iwai ; Masatsugu HoriuchiDevil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
000777 (2008) Rajesh Ponnusamy [Allemagne] ; Ralf Moll [Allemagne] ; Thomas Weimar [Allemagne] ; Jeroen R. Mesters [Allemagne] ; Rolf Hilgenfeld [Allemagne]Variable Oligomerization Modes in Coronavirus Non-structural Protein 9
000785 (2007) S. A. Bascom ; R. E. James ; M. L. Mcgilliard ; M. Van Amburgh [États-Unis]Influence of Dietary Fat and Protein on Body Composition of Jersey Bull Calves1
000792 (2006) Q. Yuan [Singapour] ; Y. Liao [Singapour] ; J. Torres [Singapour] ; J. P. Tam [Singapour] ; D. X. Liu [Singapour]Biochemical evidence for the presence of mixed membrane topologies of the severe acute respiratory syndrome coronavirus envelope protein expressed in mammalian cells
000793 (2006) Sara Kerström [Suède] ; Yee-Joo Tan [Singapour] ; Ali Mirazimi [Suède]Amino acids 15–28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies
000796 (2006) Christel Schwegmann-We Els [Allemagne] ; Georg Herrler [Allemagne]Sialic acids as receptor determinants for coronaviruses
000801 (2005) Shuo Shen [Singapour] ; Pi-Shiu Lin [République populaire de Chine] ; Yu-Chan Chao [République populaire de Chine] ; Aihua Zhang [République populaire de Chine] ; Xiaoming Yang [République populaire de Chine] ; Seng Gee Lim [Singapour] ; Wanjin Hong [Singapour] ; Yee-Joo Tan [Singapour]The severe acute respiratory syndrome coronavirus 3a is a novel structural protein
000802 (2005) Man Cheng [République populaire de Chine] ; Ceci W. L. Chan [République populaire de Chine] ; Randy C. F. Cheung [République populaire de Chine] ; Rama Kamesh Bikkavilli [République populaire de Chine] ; Qi Zhao [République populaire de Chine] ; Shannon W. N. Au [République populaire de Chine] ; Paul K. S. Chan [République populaire de Chine] ; Susanna S. T. Lee [République populaire de Chine] ; Gregory Cheng [République populaire de Chine] ; Walter K. K. Ho [République populaire de Chine] ; Wing-Tai Cheung [République populaire de Chine]Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021